Rationale: The imidazopyridine hypnotic zolpidem may produce less memory an
d cognitive impairment than classic benzodiazepines, due to its relatively
low binding affinity for the benzodiazepine receptor subtypes found in area
s of the brain which an involved in learning: and memory. Objectives: The s
tudy was designed to compare the acute effects of single oral doses of zolp
idem (5, 10, 20 mg/70 kg) and the benzodiazepine hypnotic triazolam (0.125,
0.25, and 0.5 mg/70 kg) on specific memory and attentional processes. Meth
ods: Drug effects on memory for target (i.e., focal) information and contex
tual information (i.e., peripheral details surrounding a target stimulus pr
esentation) were evaluated using a source monitoring paradigm, and drug eff
ects on selective attention mechanisms were evaluated using a negative prim
ing paradigm, in 18 healthy volunteers in a double-blind. placebo-controlle
d. crossover design. Results: Triazolam and zolpidem produced strikingly si
milar dose-related effects on memory for target information. Both triazolam
and zolpidem impaired subjects' ability to remember whether a word stimulu
s had been presented to them on the computer screen or whether they had bee
n asked to generate the stimulus based on an antonym cue (memory for the or
igin of a stimulus, which is one type of contextual information). The resul
ts suggested that triazolam, but not zolpidem, impaired memory for the scre
en location of picture stimuli (spatial contextual information). Although b
oth triazolam and zolpidem increased overall reaction time in the negative
priming task, only triazolam increased the magnitude of negative priming re
lative to placebo. Conclusions: The observed differences between triazolam
and zolpidem have implications for the cognitive and pharmacological mechan
isms underlying drug-induced deficits in specific memory and attentional pr
ocesses, as well for the cognitive and brain mechanisms underlying these pr
ocesses.